The research into deadly influenza pathogens that is happening now in labs all around the world presents a real and dangerous threat, Marc Lipsitch, director of the Center for Communicable Disease Dynamics at the Harvard School of Public Health, writes in the New York Times.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

CDC Takes Action

Pause and Deliberate

Keeping Watch

Called Back Up

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.